Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 12, Issue 11, Pages 1791-1801Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1517/13543784.12.11.1791
Keywords
drug development; heart failure; therapy
Categories
Ask authors/readers for more resources
Pharmacological therapies remain the primary strategy for treating patients with acute and chronic heart failure. Several novel neurohormonal antagonists, inotropic agents, immune modulators, and metabolic and replacement therapies are currently in development to meet the demands of an increasing number of patients with heart failure. The success in drug development in this field will require a better understanding of the effects of heart failure on drug dosing, better integration of novel and existing drug therapies, the development of more reliable surrogate markers to effectively tailor medical therapy to individual needs and the ability to detect and treat patients at risk before the onset of heart failure.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available